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It has long been held as scientific fact that soon after birth, cardiomyocytes cease dividing, thus explaining the limited
restoration of cardiac function after a heart attack. Recent demonstrations of cardiac myocyte differentiation observed
in vitro or after in vivo transplantation of adult stem cells from blood, fat, skeletal muscle, or heart have challenged
this view. Analysis of these studies has been complicated by the large disparity in the magnitude of effects seen by
different groups and obscured by the recently appreciated process of in vivo stem-cell fusion. We now show a novel
population of nonsatellite cells in adult murine skeletal muscle that progress under standard primary cell-culture
conditions to autonomously beating cardiomyocytes. Their differentiation into beating cardiomyocytes is
characterized here by video microscopy, confocal-detected calcium transients, electron microscopy, immunofluor-
escent cardiac-specific markers, and single-cell patch recordings of cardiac action potentials. Within 2 d after tail-vein
injection of these marked cells into a mouse model of acute infarction, the marked cells are visible in the heart. By 6 d
they begin to differentiate without fusing to recipient cardiac cells. Three months later, the tagged cells are visible as
striated heart muscle restricted to the region of the cardiac infarct.
Citation: Winitsky SO, Gopal TV, Hassanzadeh S, Takahashi H, Gryder D, et al. (2005) Adult murine skeletal muscle contains cells that can differentiate into beating
cardiomyocytes in vitro. PLoS Biol 3(4): e87.
Introduction
The difficulty in recovery of cardiac function after
cardiomyocyte death, such as occurs with a heart attack,
contrasts with injury to skeletal muscle in which myocyte
numbers can increase through the recruitment of new
myocytes from a local stem-cell pool called satellite cells. At
present, cardiac transplant, with the intrinsic limitations of
supply, immunosuppression, and organ rejection, remains
the only long-term treatment for irreversible cardiac failure.
Injection of fetal or embryonic stem cells into infarcted
hearts holds some promise [1,2,3] but is complicated by the
potential for immunologic rejection as well as by political and
ethical considerations. Cell plasticity observed after in vivo
transplantation of a variety of cell lineages [4,5,6,7] or after in
vitro transformation with 5-azacytidine [8] has encouraged
the study of cell-based therapy. Investigators have identified
endogenous cardiomyocyte proliferation [9] and have ex-
perimented with skeletal myoblasts as well as with adult stem
cells isolated from blood or heart to try to repair cardiac
damage [9,10,11,12,13,14,15].
In vivo analysis of stem-cell transplantation studies has
become complicated in part because of a growing under-
standing of the process of in vivo donor stem-cell and
recipient mature-cell fusion [16,17,18]. Recent studies have
shown a small population of cells in murine fat that progress
to beating cells in vitro [19]. Three independent groups have
isolated stem cells from the heart that show a capacity to
differentiate into cardiomyocytes in vivo [14,15,20]. All three
cell types are extensively passaged, after which two of these
can be pushed to differentiate in vitro.
In evaluating a variety of primary cell cultures of different
lineages, we noticed nonadherent cells isolated from adult
murine skeletal muscle that become beating floating cells. We
named them ‘‘Spoc’’ cells (skeletal-based precursors of
cardiomyocytes) for their ability to generate beating cardio-
myocytes in vitro. These cells, easily obtained from skeletal
muscle, provide new options for cardiac research and
therapeutic interventions. When injected systemically into
an acutely infarcted mouse, they migrate to the cardiac
infarct region and differentiate into cardiac myocytes.
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Results/Discussion
Characterization of Spoc Cells
At initial isolation, Spoc cells are CD34 and CD45 (data
not shown). Dissociation of 10 g of leg muscle yields
approximately 2 3 106 Spoc cells. C-kitþ cells, comprising
less than 1% of Spoc cells, are present after isolation but can
be removed by affinity purification without any change in the
subsequent results (data not shown). Electron microscopy
(EM) shows that on the day of isolation, Spoc cells are 4–8 lm
in diameter, often smaller than a red blood cell, and display
copious vesicles suggestive of active transport. Many lamelli-
podia and filopodia are present, which may in part explain
the typical Velcro-like clumping of the cells that makes
chemical and physical dispersion more difficult (Figure 1).
The CD34/CD45/c-kit phenotype differentiates Spoc cells
from other nonadherent cells previously described as derived
from skeletal muscle [5]. Spoc cells are distinguished from
satellite cells by the following criteria: (1) Spoc cells do not
express Pax-7 [21] or the surface marker c-met [22]; (2)
approximately the same number of Spoc cells are isolated
from both young (less than 4-wk-old) and older (12- to 16-wk-
old) mice, whereas satellite cells are difficult to isolate from
normal mouse muscle after 8 wk of age without first inducing
muscle injury [21]; (3) at isolation, Spoc cells remain round
floating cells approximately 4 lm in diameter, whereas
isolated satellite cells soon become adherent; (4) Spoc cells
are CD34 and Myf-5, excluding them from the class of
quiescent satellite cells [23]; and (5) the three skeletal muscle
super-regulatory genes myf5, myoD, and myogenin are known to
be present at some time in satellite cells [22], but in Spoc cells,
all three markers remain negative from the day of isolation
throughout long-term culture (data not shown). Thus, Spoc
cells are neither satellite cells nor further-differentiated
skeletal muscle cells.
During the first 7 d in medium containing epidermal
growth factor (EGF) and fibroblast growth factor (FGF), Spoc
cells undergo several rounds of division, begin to express
GATA-4 (a mostly cardiac-specific transcription factor), and
become clusters of floating round cardiac precursors from
Spoc (CPS) cells with an increased diameter of 10–14 lm. The
pattern of GATA-4 staining in these cells is unusual in that it
is predominantly cytoplasmic, which is distinct from the
expected nuclear staining of a transcription factor. Although
rare, many transcription factors are well known to have a
cytoplasmic phase. GATA-4 has been described similarly and
in this case has been shown to move into the nucleus after the
addition of the beta-adrenergic drug isoproterenol [24,25].
For these reasons, isoproterenol was added to a culture of
CPS cells for 1 h, after which GATA-4 staining was observed
in the nucleus of many of the cells (Figure 2). These cells go
on to express other cardiac-specific markers, including
cardiac troponin-T, Nkx-2.5, MLC-2v, and a cardiac L-type
calcium channel, detected either by immunostaining or real-
time PCR (Figure 3A–3G; real-time PCR data not shown).
Although Nkx-2.5 may be present in vascular smooth muscle,
neither alpha- nor beta-myosin is present in smooth muscle.
Beating cardiomyocytes derived from Spoc cells express both
alpha- and beta-myosin at day 28, as shown by staining with
polyclonal antibodies against alpha- and beta-myosin (Figure
S1). In later stages, connexin 43 is expressed in cell clusters
(Figure 3H–3I). Even before they become adherent, some
isolated cells begin to beat (Video S1).
Sca-1 Separation of Spoc Cells
Further fractionation of Spoc cells by sorting for the Sca-1
marker (a cell-surface antigen found on murine hemato-
Figure 1. EMs of Day 0 Spoc Cells
Electron micrograph of a freshly isolated Spoc cell (A) shows its small
size relative to the typical biconcave profile of the red blood cell
above it (arrow). (B) shows a typical Spoc cell with a large number of
vesicular structures, lamellipodia, and filopodia. (C) displays three
Spoc cells so tightly clumped that their borders are difficult to
distinguish. This typical clumping makes fluorescence-activated cell
sorting (FACS) analysis difficult.
DOI: 10.1371/journal.pbio.0030087.g001
Figure 2. Sublocalization of GATA-4 in Spoc Cells
(A) GATA-4 is detected in the cytoplasm of day 10 Spoc cells
(cytospin).
(B) Nomarski image of (A), showing DAPI-stained blue nuclei.
(C) Merge image showing nuclei and GATA-4 staining.
(D) When Spoc cells are incubated with 20 lM isoproterenol for 1 h,
the GATA-4 nuclear staining is seen.
(E) Nomarski image of (D).
(F) Merge of (D) and (E), showing sublocalization of GATA-4 to nuclei.
A weaker GATA-4 signal is present in the cytoplasm.
DOI: 10.1371/journal.pbio.0030087.g002
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poietic stem cells [HSCs]) shows that the beating cells develop
out of the Sca-1 pool, which comprises 20%–40% of the
total isolated cells. This is in contrast to recent studies in
which an isolated Sca-1þ population from the heart homed to
the heart after vascular injection and showed signs of cardiac
differentiation [14,26]. When the skeletal muscle–derived Sca-
1þ fraction of Spoc cells are plated under our conditions (see
Materials and Methods) separately from the Sca-1 fraction,
the former cells rapidly adhere to the plate and, with the
exception of a few putative contaminating Sca-1 cells, do not
develop into beating cells. With the Sca-1þ population
removed, the remaining Sca-1 population undergoes addi-
tional divisions before beginning to differentiate. Occasion-
ally, a small, round beating cell with no organized sarcomere
is seen after 3 d, but approximately 80% of the total
population of cells differentiates into beating cells after a 7-
to 10-d proliferative period. These Sca-1–derived CPS cells
remain in this immature state, i.e., round, loosely attached,
and spontaneously beating, for more than 2 mo of culture.
When a green fluorescent protein (GFP)–tagged Sca-1
population of CPS cells is replated onto a nontagged
adherent monolayer of the purified Sca-1þ cells, the
fluorescent Sca-1 cells adhere to the monolayer within 24
h, stretch out, and mature into beating cells. As the stretched-
out GFPþ cells develop a sarcomeric structure, the GFP signal
diminishes. This phenomenon, which is possibly due to a
down-regulation of the beta-actin promoter-driven GFP, or
to the exclusion of GFP protein from the developing
sarcoplasm, may compromise the detection of GFP-tagged
donor cells in the mouse infarct model.
Spoc Cells Are Not Derived from Bone Marrow or Adipose
Tissue
Spoc cells do not appear to be bone marrow cells
sequestered in skeletal muscle, and because they are c-kit,
they are distinguished from the c-kitþ bone marrow cells and
side population cells that have been used directly or indirectly
in experiments to reconstitute infarcted heart [11,13]. When
approximately 50 mg of whole marrow or dissociated total
heart is co-cultured in permeable-membrane-separated com-
partments in a 1:1 ratio with Spoc cells, only the Spoc cells
develop into beating cardiomyocytes. Thus, bone marrow and
heart do not contain a cell population that is isolatable in this
manner and phenotypically similar to Spoc cells.
We also performed experiments to determine whether Spoc
cells are similar to adipocyte-derived stroma vascular fraction
cells (SVFs), which have been derived from a mixture of
murine inguinal and intrascapular fat pads [19]. Spoc cells
were cultured in parallel with SVFs in our EGF/FGF–
containing medium, as well as in methocult supplemented
with beta-mercaptoethanol, erythropoietin, Interleukin (IL)–
3, IL-6, and Stem Cell Factor, as outlined in [19], except that
inguinal- and intrascapular-derived cells were kept separate
from each other. In the supplemented methocult culture,
Spoc cells developed into CPS cells, which subsequently fused
into large (up to 1 mm in length) beating myocytes as
described earlier [19]. We were not able to generate CPS cells,
or any beating cells, from SVFs derived from inguinal fat
alone. A result similar to culturing Spoc cells was observed
with intrascapular-derived SVFs cultured in supplemented
methocult, but only in cultures that had microscopic
contamination with skeletal muscle fibers. Neither SVFs from
the inguinal nor from the intrascapular fat pads yielded any
beating cells when cultured under standard EGF/FGF Spoc cell
conditions. Planat-Benard et al. [19] report an efficiency of
conversion to cardiomyocytes of 0.02%–0.07%, whereas 1%–
10% of total Spoc cells become beating cardiomyocytes. When
pure Sca-1 Spoc cells are plated, after the proliferation
phase, approximately 80% of the cells are beating CPS cells.
Unlike the case with HSCs, no colony-forming units are
generated when Spoc cells are cultured in methylcellulose in
the presence of erythropoietin, IL-3, IL-6, and Stem Cell
Factor (data not shown). To evaluate the ability of Spoc cells
to reconstitute bone marrow, standard and competitive bone
marrow transplantations with Spoc cells were performed. In
four mice, 33106 bone marrow cells and 33104 GFP þ/Sca-1
Spoc cells were injected into each of the lethally irradiated
mice. All four mice survived; however, only a rare GFPþ
donor–derived cell was seen in the peripheral blood or bone
marrow (data not shown). The marrow of six lethally
irradiated mice, injected with either 1.5 3 105 Sca-1 Spoc
cells or 23 105 Spoc cells unfractionated for Sca-1, could not
be rescued, and all six mice died within 2 wk. Thus, because
only a single HSC is required to reconstitute bone marrow,
no HSCs are contained in 23 105 Spoc cells.
Transmission EM of CPS Cells as They Progress to Beating
Cells
Figure 4 shows the post-replating progression of CPS cells.
Three days after the replating of floating cells (see Materials
and Methods), when increasing numbers of CPS cells show
rhythmic beating, EM shows round cells with large central
nuclei surrounded by copious mitochondria and myosin thick
Figure 3. CPS Cells Stain Positive for Cardiac-Specific Proteins
(A) GATA-4 in day 7 CPS cells.
(B) Nuclear staining with DAPI.
(C) Overlay of (A) and (B).
(D) Nkx-2.5 is detected in the nuclei of round, day 21 beating cells
(green).
(E) Noncardiac cells (red arrowheads) do not show nuclear staining
for Nkx-2.5.
(F) Overlay of (D) and (E).
(G) Beating cells, after 28 d in culture, stain positive for cardiac L-
type Caþþ channel.
(H) Connexin 43 (green) in cluster of uninucleate day 21 beating cells
in culture.
(I) Nomarski light micrograph (differential interference contrast) of
cell cluster in (H).
DOI: 10.1371/journal.pbio.0030087.g003
PLoS Biology | www.plosbiology.org April 2005 | Volume 3 | Issue 4 | e870664
Cardiomyocytes from Skeletal Stem Cells
filaments (Figure 4A and 4D). As the cells attach to the tissue
culture plate, the central nucleus elongates and electron-
dense structures are visible (Figure 4B; arrowhead in Figure
4E), with myosin filaments radiating outward (box/inset,
Figure 4B). By 2 wk, the electron-dense bodies have begun
to align with filaments coursing between them (Figure 4C).
These structures are nearly identical to those seen in
embryoid body–derived developing cardiomyocytes [27]. By
8 wk in culture, the electron-dense structures in EMs of
beating cells have progressed to become the Z-lines of
organized sarcomeres (Figure 4G). The beating cells also have
one or two large, centrally located nuclei surrounded by
mitochondria, distinguishing them from skeletal myotubes,
which have many small, subsarcolemmal nuclei.
Calcium Transients and Cardiac Action Potentials in CPS
Cells
As the CPS cells progress to spontaneously beating cardio-
myocytes in vitro, the frequency of beating ranges from 1 to 8
Hz. Cells continue to beat even after culture for 3 mo. Despite
the absence of beating initially, some clusters of cells adherent
to an extracellular matrix display calcium transients detected
by fluo-4 (4 lM concentration) visualized with confocal
microscopy (Video S2). This suggests that the excitation
portion of ‘‘excitation–contraction’’ develops before the
contractile apparatus of the cell is mature enough to overcome
the minimal resistance offered by an extracellular matrix. The
round beating cells shown in Video S1 progress to the elliptical
beating cells shown in Video S3 and subsequently to the more
mature cardiomyocytes shown in Video S4. These last cells also
display calcium transients detected through the use of fluo-3 (4
lMconcentration) as shown inVideo S5 andFigure 5. By day 14
after replating, 10% of the cells in a confluent dish beat
spontaneously. The calcium transients indicate the existenceof
action potentials (APs), which have been characterized by
patch recordings of single cells in culture (Figure 6). A variety of
cardiac APs are observed in beating and nonbeating cells
(Figure 6A and 6B), which both show a resting membrane
potential of approximately60 mV with a robust overshoot of
50–90 mV. The form and duration of the APs match the
descriptions of adult murine cardiomyocyte APs, which lack
the plateau phase seen in cardiomyocytes of other species [28].
Figure 4. Transmission EMs Show the Post-Replating Progression of CPS Cells
(A) Round, day 3 cells contain disordered myosin filaments. Some of these cells beat while still floating (see Video S1) and typically have APs as
shown in Figure 6A.
(B) Upper box is a blowup taken from lower panel, showing myosin filaments of characteristic 1.6-lm length radiating outward from dense body.
(C) Day 14 cell with a single, central nucleus shows a stretching out of the dense bodies into an organizing sarcomere.
(D) Day 3 round cells containing copious mitochondria (inset).
(E) Elongated day 7 cell containing a dense body (arrowhead).
(F) Uninucleate day 14 cell, same cell as in (C).
(G) By day 56, a well-defined sarcomere is present, with identifiable A- and I-bands and M- and Z-lines.
(H) Sarcomere from a fetal cardiomyocyte is shown for comparison.
DOI: 10.1371/journal.pbio.0030087.g004
Figure 5. Measuring Calcium Transient Frequency
Graphical representation of the calcium transient in a beating CPS
cell–derived cardiomyocyte (A). Fluorescent intensity is proportional
to the amount of calcium binding to fluo-3 dye upon release of
calcium from the sarcoplasmic reticulum. Peak intensity (B) and
baseline (C) are shown.
DOI: 10.1371/journal.pbio.0030087.g005
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The beating in Spoc cell–derived cardiomyocytes differs
from the sporadic twitches that have been observed in
skeletal muscle because the addition of 0.5 mM cadmium
chloride, a non-specific blocker of L-type Caþþ and Naþ
channels, abolishes the cardiac AP [29,30], while having no
effect on skeletal myotubes (Figure 6C and 6E) [31,32].
Likewise, both beating and nonbeating cardiac cells have an
intact adrenergic pathway [33,34,35], as shown by the increase
in AP frequency with the addition of 25 nM isoproterenol
(Figure 6D). The expected lack of effect on skeletal myotubes
[36] is shown in Figure 6F. Uninucleate myoblasts with
spontaneous calcium transients and APs under standard
culture conditions have not been described [37], and even
when they are contrived by arresting cell fusion, they retain
the electrical activity characteristic of skeletal muscle cells,
such as the lack of response to cadmium chloride [38].
Transplantation of Spoc Cells into Murine Myocardial
Infarction Models
In order to determine whether Spoc cells engraft within a
myocardial infarct (MI) and differentiate into mature
cardiomyocytes, an acute infarct model in C57Bl/6J mice
was created by ligation of the left coronary artery. We
injected 1 3 105 GFPþ total Spoc cells (unfractionated for
Sca-1) into the peripheral circulation. After 14 wk, many
donor-derived GFPþ cells had engrafted (Figure 7B). Of
donor cells that had migrated to the infarct, 8% (63/782)
had developed into cardiomyocytes (arrows, Figure 7A)
displaying a phosphorylated cardiac myosin regulatory light
chain (RLCP), shown by co-labeling with an antibody against
GFP (green) and RLCP (red) [39]. All samples were scanned
on green and red channels simultaneously. Cells were
considered GFPþ only if their cytoplasm fluoresced green
and not red. This prevents mistaking the anti–GFP signal
(green) in Figure 7A for autofluorescence. Autofluorescence
in an infarct will characteristically ‘‘bleed’’ through both
green and red channels in the absence of exogenous
fluorescent markers, causing all autofluorescence to show
up as a generalized yellow, i.e., the combination of red and
green [40]. In this case, only the myosin striations, which are
co-stained, appear as both red and green, serving as an
internal control for the technique. No labeled cells, differ-
entiated or undifferentiated, were observed in the normal
portion of the infarcted heart (data not shown). These
findings suggest that Spoc cells either actively home to or
are passively delivered to an area of cardiac damage where
they begin to differentiate into cardiomyocytes, as observed
in vitro. In order to determine if Sca-1 Spoc cells engraft
and differentiate within a MI as efficiently as Spoc cells
unfractionated for Sca-1, the same acute anterior MI model
described earlier was used. When 13 105 Sca-1/GFPþ donor
cells were injected via the tail vein immediately after
infarction, a low level of engraftment occurred with only
an occasional donor-derived cardiomyocyte found at the
periphery of the infarct zone (Figure 7C–7E). This finding is
consistent with our in vitro findings described earlier, in
which purified Sca-1 cells remained immature, loosely
attached, round beating cells for months until co-culture
with a feeder layer of immobile Sca-1þ cells allowed the Sca-
1 fraction to adhere and mature.
Figure 6. Whole-Cell Voltage Recordings from Spoc Cell–Derived Cardiomyocytes
(A) Spontaneous AP firing in a nonbeating, teardrop-shaped cell.
(B) Representative AP from recording in (A) on an expanded time scale; AP threshold is –60 mV.
(C) Action potential firing in another cell is blocked upon bath perfusion with 0.5 mM cadmium chloride (horizontal bar).
(D) Acceleration of AP firing upon perfusion with 25 nM isoproterenol (horizontal bar) is demonstrated, indicating the presence of adrenergic
receptors on these cells.
(E) Skeletal myotube APs, if present, differ in that their frequency is unaffected by Cdþþ.
(F) Isoproterenol also does not affect skeletal muscle AP frequency.
DOI: 10.1371/journal.pbio.0030087.g006
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To evaluate for a similar effect in an older infarct, the same
number of Spoc cells, unfractionated for Sca-1, was injected
via the tail vein into two mice (8 and 14 wk after MI). Two
weeks after injection, the heart of the 8-wk-old infarct model
showed co-localization of GFP and GATA-4 in 3% (4/136) of
donor cells that migrated to the peripheral region of the
infarct. Five weeks after injection into the 14-wk-old infarct
model, an increased number of GFPþ/RLCPþ cells (7/102
donor-derived cells) in the infarct region were evident (data
not shown). Spoc cells that were partially differentiated by
culturing for 7 d were injected into the hearts and tail veins of
three mice with acute infarcts. No labeled cells were identified
in the hearts at 7 d and 1 mo later, compared to two control
mice injected with saline at the time of infarct (data not
shown). This suggests that the undifferentiated cells more
easily actively home to or are delivered passively to the heart.
We used a Cre-recombinase (Cre) expressor/beta-galacto-
sidase reporter system to rule out donor stem-cell fusion with
host cardiomyocytes as an explanation for apparent in vivo
differentiation. In the event of fusion, Cre from the donor
cells will excise the floxed stop codon present in the host
DNA and thus de-repress the beta-galactosidase reporter
gene. Within hours of producing an acute infarct by surgical
ligation of the left coronary artery in R26Rh reporter mice,
tail-vein injection of 3 3 105 Creþ Spoc cells from an EIIa
promoter/Cre donor mouse was performed. Creþ donor cells
are seen in the heart as early as 2 d post infarct (data not
shown). By day 7, isolated nests of donor cells that have not
fused with host cells can be detected, as shown by the lack of
X-gal staining in Creþ cells (Figure 8A–8F). Also by day 7,
GATA-4 is co-expressed with Cre in some of the cells in these
clusters (Figure 8G–8I). In order to further isolate and track
donor Spoc cells, a monoclonal antibody library was
generated by inoculating a rat with live Spoc cells via
injection into the peripheral circulation. The library was
screened for the ability to detect cell-surface antigens on total
Spoc cells. One such antibody that has been generated (MSC
21) detects live Spoc cells in culture and can be used to isolate
a positive and negative subpopulation. MACS separation
using MSC 21 gives two populations, with the 21þ subset
containing cells that develop into beating cardiomyocytes
(Video S6). In the Cre donor/R26Rh reporter infarct mice,
some of the injected Creþ cells are co-stained by MSC 21,
further supporting the donor origin of these transplanted
cells (Figure 8J–8L). MSC 21 does not detect cells in normal
controls or infarcted heart (Figure 8M).
Concluding Remarks
Our isolation and description of what we call Spoc cells was
initially surprising to us in that a few simple variations in the
usual technique of skeletal muscle cell culture yielded a novel
finding. These adaptations included avoiding trypsin, sub-
stituting FGF and EGF for commonly used complex supple-
ments like chick embryo extract, and discarding adherent
cells while continuing to culture the nonadherent cells. The
observation of isolated nonadherent beating cells in a skeletal
muscle culture has probably been observed previously by
others in the course of experimenting with skeletal muscle
culture conditions but has anecdotally been considered to be
some variant of primitive skeletal muscle cells and never been
carefully investigated . This report is, to our knowledge, the
first time that the phenotype of these cells has been
methodically studied with single-cell patch recordings, Caþþ
transient recordings, EM, longitudinal video microscopy, and
immunostaining to detect the presence of skeletal and
cardiac histologic markers. The absence of skeletal and
satellite cell markers in the face of the histologic and
physiologic evidence of the cardiac phenotype supports our
conclusion that these cells are closer to true cardiac myocytes
than to some variant of skeletal muscle cells. The homing of
these freshly isolated cells to the injured heart and their
subsequent differentiation into a cardiac phenotype in vivo
that matches the in vitro experiments is corroborating
evidence.
Recently, three independent groups have isolated a stem-
cell population from the heart. In two studies, the stem cells
were cultured extensively [15,20] before reintroduction
directly into the heart, whereas in the other study, freshly
isolated cells were injected into the vascular circulation [14].
Beltrami et al. [15] did not observe beating cells in vitro,
whereas the cells isolated by Oh et al. [14] required treatment
with the demethylating agent 5-azacytidine to produce
beating cells, similar to the treatment that was previously
used to generate beating cell lines from bone marrow stromal
cells [41]. Messina et al. [20] used cardiotropin to treat round
cells released from a 3-wk explant culture, generating a
sphere of cells that remain primitive and proliferating on the
inside while they differentiate into beating cardiac myocytes
at the margins. They observed that this growth pattern is
reminiscent of neurospheres. All three cardiac-derived
populations appear to be distinct from one another with
respect to parameters such as the presence of c-kit or the
ability to beat in vitro; however, the diverse conditions make
direct comparison difficult.
Figure 7. In Vivo Myocardial Infarction Transplantation Studies
(A) The GFP-tagged Spoc cells (green), unfractionated for Sca-1,
injected into the peripheral blood of a murine acute infarct model
have developed after 14 wk into cardiomyocytes (arrows) within the
infarct region. Donor Spoc cell–derived GFP cardiomyocytes are
characterized by single central nuclei and striations staining for
RLCP (red).
(B) Longitudinal fresh-frozen tissue slice showing the region of
infarct from which (A) was taken (orange box) and adjacent normal
endogenous cardiac tissue (RLCP, red).
(C) GFPþ/Sca-1 Spoc cells were injected into the peripheral
circulation of a murine acute MI model and are detected in the
infarct after 4 wk by expression of GFP (green).
(D) RLCP (red) is also expressed.
(E) Overlay of (C) and (D).
DOI: 10.1371/journal.pbio.0030087.g007
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Spoc cells do not emerge from cardiac tissue grown in
parallel with the skeletal cultures. However, freshly isolated
Spoc cells are observed in infarcted heart within 2 d of their
systemic injection into a murine model of acute MI. Within 7 d
of systemic injection, Spoc cells form a sphere-like body at the
borders of the infarction near blood vessels. The Cre signal is
strongly present in the center of these spheres but diminished
at the borders where the GATA-4 signal emerges. This is likely
due to EIIa promoter suppression in the differentiating cells.
This pattern of the more proliferative cells in the center and
the differentiating cells at the borders is reminiscent of
neurospheres or the in vitro culture of cardiac-derived stem
cells [20]. By 3 mo, many more of the cells are distributed
throughout the border areas of the infarct and can be
detected with an antibody to ventricular RLCP.
The pattern of GATA-4 staining in early Spoc cells is
particularly interesting in its unusual cytoplasmic distribu-
tion, but the shift to a nuclear distribution after the addition
of the beta-adrenergic agonist isoproterenol to the cell
culture illustrates the staining specificity. The importance
of beta-adrenergic stimulation to the processes of differ-
entiation and cardiac myocyte hypertrophy makes these cells
Figure 8. Cre Expressor/Beta-Galactosidase Reporter Myocardial Infarction Studies
(A) Nests of Creþ cells (green) are detected 1 wk after tail-vein injection into an acute infarct model.
(B) Nomarski image of (A).
(C) Merged image of (A) and (B). The clusters are located near a blood vessel (arrow).
(D) Infarcted tissue in a control MI model (infarction surgery but no donor-cell injection) showing a lack of staining for Cre (no green) and
GATA-4 (no red).
(E) Control X-gal staining of ROSA mouse heart.
(F) In a sequential series of tissue sections, odd-numbered sections were immunostained for Cre, yielding the results seen in (A). These two
clusters of cells were seen on five sections (sections 1, 3, 5, 7, and 9). Even-numbered sections (sections 2, 4, 6, and 8) were stained for X-gal. No X-
galþ cells were found. One slide was immunostained, showing the Creþ cells present. This slide was then stained for X-gal and was found to be X-
gal. The lack of X-gal staining of the serial sections indicates that at 1 wk no fusion of donor and host cells has occurred in the infarct.
(G) Cluster of Creþ donor cells detected in infarcted heart tissue of a 1-wk-old acute infarct model. Arrowheads indicate cells that also express
GATA-4, as shown in (H).
(H) GATA-4 (red) is mostly present in some cells in the margin of the cluster. Arrowheads indicate cells that also express Cre, as shown in (G)
(I) Merged image showing co-localization (arrowheads) of Cre (green) with GATA-4 (red) in some cells of the cluster of Creþ cells.
(J–L) Co-staining of donor cells with anti–Cre antibody (green) and MSC 21 (red) is apparent after 7 d in an acute infarct model.
(M) There is a lack of staining with MSC 21 (no red) in the infracted tissue of mice that have not received Spoc cell injections.
DOI: 10.1371/journal.pbio.0030087.g008
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particularly useful to study the Akt–GSK3 beta regulation of
nuclear-expressed GATA-4 [25] as well as its beta-adrenergic–
mediated interaction with the calcineurin pathway [24].
Although the beating cells in vitro contract asynchronously,
local regions of confluent plates appear to beat at distinct
rates. This fact, coupled with the late expression of connexin
43 in vitro (see Figure 3H), suggests the potential for coor-
dinated beating, a requirement for efficient cardiac contrac-
tion. Although Spoc cells appear more efficient at homing to
the heart in an acute MI model, their ability to differentiate in
vivo at the border of an old infarctmay aid research focused on
chronic heart failure or dilated cardiomyopathy. Generation
of cardiomyocytes from Spoc cells derived from transgenic
models may be an important tool in studying cardiac
development, because the progression from undifferentiated
cells to mature cardiomyocytes may be observed in vitro.
Why these cardiac stem cells are sequestered in skeletal
muscle and why clinically significant numbers of them are not
normally recruited to salvage an infarcted heart remains a
mystery. Perhaps additional cells or factors present in skeletal
muscle suppress the cardiac differentiation of Spoc cells in
situ or inhibit migration. Certainly, Spoc cells do not
differentiate into cardiac cells while they reside in skeletal
muscle. Along these lines, fractionation of Spoc cells based on
Sca-1 greatly enriches for a population of cells in the Sca-1
fraction that in vitro become beating cardiomyocytes;
however, engraftment of these Sca-1 cells in MI models
seems less efficient than that of unfractionated Spoc cells.
This is consistent with the increased magnitude and kinetics
of cardiomyocyte differentiation observed when the Sca-1
fraction is plated over a monolayer of the Sca-1þ fraction.
Thus, there is likely a role for the Sca-1þ fraction in
engraftment efficiency through any number of mechanisms,
including migration, tropism, and entrapment. It remains to
be determined whether Spoc-cell transplants contribute to
mouse survival or electrically couple to endogenous cardiac
myocytes. There is evidence, however, that Spoc cells survive
more than 3 mo post transplant, during which time they
mature into striated cardiomyocytes.
Materials and Methods
Isolation of Spoc cells. To isolate cardiomyocyte precursor cells
from adult mouse skeletal muscle, skeletal muscle tissue from the hind
legs of 6- to 14-wk-old male C57Bl/6J mice is cut into small pieces and
digestedwith collagenase type-2 (5mg/ml) for 45min at 37 oC, and then
for another 45 min at 37 oC in a shaking rotator. The digested tissue is
cleared of cell debris and other undigested tissue fragments by passage
first through 100 lm and then through 40 lm filters. Cells are
incubated in DMEM/F12 medium containing 5% FBS for 2 h at 37 oC.
The cell suspension is then centrifuged at 1,500 RPM for 15 min. The
pellet consists mostly of small cells, 4–10 lm in diameter. These cells
are dispersed by trituration and are then sorted using anti–Sca-1
antibody on Miltenyi Biotech (Bergisch Gladbach, Germany) magnetic
columns so that the Sca-1 cells from total hind leg muscles of five to
eight mice are passed sequentially through three to four columns to
obtain a high degree of Sca-1 purity (.95% by fluorescent staining).
Cells are plated at a density of approximately 105 cells/cm2 in
regular tissue culture dishes in 50:50 DMEM/F12 supplemented with
5% FBS, 10 ng/ml each of human EGF and bFGF (Peprotech, Rocky
Hill, New Jersey, United States), insulin, transferrin, selenium,
ethanolamine (ITS-X; Invitrogen, Carlsbad, California, United States
), and antibiotics (gentamicin and fungizone). Within 24 h, it is clear
that the Spoc cells eluted in the Sca-1 fraction consist of mostly
nonadherent round cells, whereas the Sca-1þ fraction consists of
mainly adherent cells. Within 48–72 h, the Sca-1 culture consists of a
floating population of round cells and scant adherent fibroblasts. The
round cells enlarge as they divide in this medium, undergoing a few
rounds of cell division. The floating population of round cell clusters
is gently collected after 7 d of growth in complete growth medium
and replated in the same medium, minus EGF and bFGF. The cells,
which have enlarged to 10–14 lm in diameter, are by now GATA-4
positive. Spontaneously beating cells are visible while they are still
floating or loosely attached, but the number of beating cells increases
within a few days of replating as the cells elongate and attach to the
floor of the tissue culture plate. The beating cells do not undergo any
more cell divisions and can be maintained in this medium for several
weeks, displaying a spontaneous beating phenotype.
Alternatively, the total population of Spoc cells, unfractionated for
Sca-1, can be plated in growth-factor-containing medium for 3–5 d
and then the nonadherent cells removed carefully and replated
without growth factors. This will result in a greater population of
what will become adherent cells in the replated culture. This allows
the nonadherent Spoc cells to adhere and stretch out into more
mature beating cardiomyocytes. The isolation and differentiation of
Spoc cells from skeletal muscle is extremely reproducible and has
been performed successfully in our laboratory hundreds of times.
These cells have been used for characterization, as described in the
text, at different times after the initiation of the culture.
Transmission EM. For routine transmission EM, cells were fixed in
situ on petri dishes with 1.25% glutaraldehyde in 0.1M cacodylate
buffer containing 1% cadmium chloride at 4 oC for 2 h. After
fixation, cells were washed three times in Sabatini’s solution (0.1 M
cacodylate buffer containing 6.8% sucrose), and post-fixed with 1%
osmium tetroxide in cacodylate buffer for 1 h. After three washes in
Sabatini’s solution, samples were dehydrated in alcohol and
embedded in Scipoxy 812 (Energy Beam Sciences. Agawarm,
Massachusetts, United States). Polymerization was carried out at 37
oC for 24 h and then at 60 oC overnight. Ultra-thin sections were cut
with a Leica Ultracut UCT ultramicrotome (Leica, Wetzslar,
Germany), stained with uranyl acetate and Reynolds lead citrate,
and examined with a JEOL 1200 CXII transmission electron micro-
scope (JEOL, Peabody, Massachusetts, United States).
Confocal imaging and detection of calcium transients. The images
were collected with a Zeiss LSM-510 laser scanning confocal system
and a Zeiss C-Apochromat 63x objective (1.2 NA). Fluo-3 and fluo-4
were excited at 488 nm with an argon laser, and the emission light was
collected using an LP 505 filter. The pinhole was adjusted to produce
a 5-lm slice to minimize axial movements with contraction that may
affect viewing the calcium transients. All transmitted light images
were collected simultaneously using a transmitted light detector in
conjunction with the 488-nm excitation light. Data depth for the
images was 8 bit. The size of the images varied from 5123 512 pixels
to 1283 128.
Whole-cell clamp recordings. Current clamp recordings were
carried out using the tight-seal whole-cell patch technique at room
temperature in Tyrode solution containing 136 mM sodium chloride,
5.4 mM potassium chloride, 1 mM magnesium chloride, 1.8 mM
cadmium chloride, 0.33 mM sodium phosphate monobasic mono-
hydrate, 10 mM glucose, and 10 mM HEPES (adjusted to pH 7.4 with
sodium hydroxide). The pipette solution contained 20 mM potassium
chloride, 110 mM potassium aspartate, 1 mM magnesium chloride, 10
mM HEPES, 5 mM EGTA, 0.1 mM GTP, and 5 mM Mg2þ/ATP
(adjusted to pH 7.2 with potassium hydroxide). Voltages were filtered
at 2 kHz (–3 dB; four-pole, low-pass Bessel filter). The resting
membrane potential upon breaking in was –39.8 6 1.6 mV (n = 9),
but it generally improved by 10 mV or more. In some cases, cells were
hyperpolarized slightly to AP threshold.
Immunostaining. Cells were fixed in either 4% paraformaldehyde
at 4 oC, neutral buffered 10% formalin at 4 oC, or acetone at –20 oC
for 10 min and then washed in PBS for a total of 15 min (three times).
Cells were permeabilized with 0.2% Triton X-100 for 10 min.
Blocking was performed for 30 min at room temperature with either
3% BSA in PBS, 5% goat serum in PBS, or 10% goat serum in PBS.
Incubation with primary antibody was performed at 4 oC overnight.
Cells were then washed for a total of 15 min (three times) in 1X PBS.
Incubation with secondary antibody was done at room temperature
for 1 h. Afterwards, cells were washed three times with PBS and
mounted in a fluorescent mounting medium with 49,6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories, Burlingame, California,
United States). A cover slip was then placed over the sample. Images
of cells were obtained with a laser scanning confocal fluorescence
microscope (Leica TCS-4D DMIRBE) equipped with argon and
argon–krypton laser sources. Excitation wavelengths of 365 nm
(DAPI), 488 nm (FITC), and 568 nm (rhodamine) were used to
generate fluorescence emissions in blue, green, and red, respectively.
The primary antibodies used were against MyoD (Novocastra
Laboratories, Newcastle-upon-Tyne, United Kingdom), GFP (Abcam,
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Cambridge, United Kingdom), cardiac L-type channel (United States
Biological, Swampscott, Massachusetts, United States), Sca-1 (Cedar-
lane Laboratories, Hornby, Ontario, Canada), and CD34 and CD45
(PharMingen, San Diego, California, United States). GATA-4, Myf-5,
Myogenin, connexin 43, Nkx-2.5 Pax-3/7, c-met, and c-kit antibodies
were from Santa Cruz Biotechnology (Santa Cruz, California, United
States). The antibody to RLCP was produced in our laboratory and
has previously been described [39]. Alpha-myosin antibody has been
produced and characterized by our laboratory and is unpublished.
Beta-myosin antibody was produced by our laboratory and previously
published [42]. Antibody MSC 21 was generated after peripheral
blood injection of Spoc cells into rats (performed by Antibody
Solutions, Palo Alto, California, United States). Figure S1 was taken
using a Zeiss Axiovert 200M microscope in conjunction with Compix
(Lake Oswego, Oregon, United States) deconvolution software. To
perform GATA-4 sublocalization studies, CPS cells in culture dishes
(day 10) were incubated with 20 lM isoproterenol at 37 oC for 1 h.
Cells were then collected by trituration, cytospins were made, and
cells were stained for GATA-4, as described earlier.
Bone marrow transplantation studies. Eight 1-wk-old C57Bl/6J
mice were irradiated with one total dose of 850 cGy. Four hours after
irradiation, mice were injected via the tail vein with either 1.53 105
GFPþ/Sca-1 Spoc cells or 23 105 unfractionated GFPþ/Spoc cells. A
competitive assay was performed by injecting mice with 33106 whole
bone marrow cells and 3 3 104 GFPþ/Sca-1 Spoc cells. Mice were
evaluated for GFPþ cells in the peripheral blood and bone marrow.
MI studies. Sixteen 1-wk-old male C57Bl/6J mice were administered
Avertin (1.25%, tribromoethanol) at 0.015 ml/g body weight or
pentobarbital diluted to 0.5% and administered at 100 mg/kg IP.
Animals were intubated by direct visualization, and ventilation was
performed. Once anesthetized, hair in the surgical field was removed,
and a thoracotomy was performed. Heart was visualized after
retractors were used to enlarge the incision. The left anterior
descending artery was permanently ligated using 5-O silk suture. The
chest was closed with sutures. For acute infarct models, mice were
monitored for recovery from anesthesia and then injected (2 h post
surgery) with 1 3 105 C57Bl/6J Spoc cells (either fractionated or
unfractionated) via the tail vein. Mice were sacrificed at 14 wk; the
hearts were excised and fresh frozen sections made. For chronic
infarct models, infarction protocol was performed as described
earlier. The mice were maintained for either 8 or 14 wk before
injection of 13105 Spoc cells into the tail vein. Mice were sacrificed at
either 2 or 5 wk post injection, and the hearts were harvested for frozen
sections. For Cre expressor/beta-galactosidase reporter MI studies, the
infarct procedures described earlier were performed in 16-wk-old
R26Rh mice. We obtained 33 105 donor cells from 8-wk-old EIIa/Cre
mice and injected the cells via the tail vein on the day of surgery.
Animal studies were created under National Institutes of Health
protocols 2-MC-31(R) and 1-CB-2, in accordance with the guidelines
set forth by the National Heart, Lung, and Blood Institute Animal
Care and Use Committee.
Supporting Information
Figure S1. Day 28 Spoc-Derived Cardiomyocytes Express Alpha- and
Beta-Myosin
(A) Day 28 Spoc cell–derived cardiomyocytes express alpha-myosin,
as shown by immunostaining using anti–alpha-myosin antibody.
(B) Beta-myosin is also present in these cells.
Found at DOI: 10.1371/journal.pbio.0030087.sg001 (531 KB TIF).
Video S1. Round Beating Cell in Culture
Video microscopy of round, spontaneously beating cell about 10 d
from isolation (diameter = 15 lm), at approximately the stage shown
in Figure 4D.
Found at DOI: 10.1371/journal.pbio.0030087.sv001 (5.1 MB MPG).
Video S2. Calcium Transients in Beating and Nonbeating CPS Cells
Calcium transients are present in a cluster of day 14 beating cells in
culture as detected by fluo-4 fluorescent dye. Only some of the cells
with detectable calcium transients are visibly contracting, which
shows an uncoupling of excitation–contraction, presumably because
of an immature contractile apparatus or decreased movement caused
by a dense extracellular matrix.
Found at DOI: 10.1371/journal.pbio.0030087.sv002 (7.0 MB MPG).
Video S3. More Mature Beating Cells Appear Elliptical
The round beating cell shown in Video S1 has progressed by day 14
after replating to an elliptical cell (length = 30 lm) that continues to
display small contractions as shown by video microscopy.
Found at DOI: 10.1371/journal.pbio.0030087.sv003 (7.4 MB MPG).
Video S4. Mature Beating CPS Cell–Derived Cardiac Myocyte in
Culture
Beating cell in culture (length = 55 lm). Spontaneous beating is
continuous (frequency 1–6 Hz) and appears to be indefinite. Cells
kept at room temperature have been noted to beat continuously for
at least 3 h, and 3-mo-old cultures contain beating cells.
Found at DOI: 10.1371/journal.pbio.0030087.sv004 (7.6 MB MPG).
Video S5. Beating Cells Exhibit Calcium Transients
Calcium transients are seen in a day 21 beating cell, as detected by
fluo-3 fluorescent dye. Flashes indicate binding of calcium to fluo-3
upon release of calcium from the sarcoplasmic reticulum.
Found at DOI: 10.1371/journal.pbio.0030087.sv005 (3.5 MB MPG).
Video S6. MSC 21 Selects for a Subset of Cells That Develop into
Beating Cardiomyocytes
A cluster of beating cardiomyocytes derived from MACS-separated
MSC 21þ cells is shown here after 14 d in culture.
Found at DOI: 10.1371/journal.pbio.0030087.sv006 (9.2 MB AVI).
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